Ruben Reyes

1.3k total citations
15 papers, 158 citations indexed

About

Ruben Reyes is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Ruben Reyes has authored 15 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Hematology. Recurrent topics in Ruben Reyes's work include Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Ruben Reyes is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Ruben Reyes collaborates with scholars based in United States, Canada and Switzerland. Ruben Reyes's co-authors include Kapil N. Bhalla, Omar S. Aljitawi, Joseph P. McGuirk, Jo Wick, Casey Williams, Suman Kambhampati, Sunil Abhyankar, Warren Fiskus, Catherine Dutreix and Jie Yu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Molecular Cancer Therapeutics.

In The Last Decade

Ruben Reyes

15 papers receiving 156 citations

Peers

Countries citing papers authored by Ruben Reyes

Since Specialization

Citations

This map shows the geographic impact of Ruben Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruben Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruben Reyes more than expected).

Fields of papers citing papers by Ruben Reyes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruben Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruben Reyes. The network helps show where Ruben Reyes may publish in the future.

Co-authorship network of co-authors of Ruben Reyes

This figure shows the co-authorship network connecting the top 25 collaborators of Ruben Reyes. A scholar is included among the top collaborators of Ruben Reyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruben Reyes. Ruben Reyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	ABCL-777: Initial Results From LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) 2025 ·Clinical Lymphoma Myeloma & Leukemia ·Juan Pablo Alderuccio, Craig Okada, (unknown), Emily C. Ayers, Marie Hu, Silvia Ferrari, Paolo F. Caimi, Mehdi Hamadani, Julien Depaus, Enrico Derenzini, Jose Sandoval‐Sus, Ruben Reyes, (unknown), (unknown), Alexander Graf, (unknown), (unknown), (unknown)	1
2	Epigenetic Silencing of MTAP in Hodgkin's Lymphoma Renders It Sensitive to a 2 nd Generation PRMT5 Inhibitor 2023 ·Blood ·Jelena Urosevic, James T. Lynch, (unknown), Nevin Yusufova, (unknown), Paul Waring, Ted Hong, (unknown), Haiyun Wang, (unknown), (unknown), Ho Man Chan, Ruben Reyes, Susan E. Critchlow, Anas Younes, Emma Dean	2
3	Online Radiation Experiment on Gamma-Ray Absorption from an Early Quack Device 2022 ·The Physics Teacher ·(unknown), (unknown), Ruben Reyes, (unknown), (unknown)	1
4	Locally Advanced Breast Implant-Associated Anaplastic Large-Cell Lymphoma: A Case Report of Successful Treatment with Radiation and Chemotherapy 2015 ·Frontiers in Oncology ·Christopher Estes, Da Zhang, Ruben Reyes, Richard Korentager, Marilee McGinness, C.E. Lominska	12
5	Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma 2014 ·Blood Cancer Journal ·Sarit Assouline, Elizabeth Chang, Bruce D. Cheson, Robert M. Rifkin, Solomon I. Hamburg, Ruben Reyes, (unknown), Jie Yu, Neeraj Gupta, Alessandra Di Bacco, Yaping Shou, Peter Martin	44
6	A potential regulatory loop between Lin28B:miR-212 in androgen-independent prostate cancer 2014 ·International Journal of Oncology ·Emma Borrego-Diaz, Benjamin Powers, Vugar Azizov, Scott Lovell, Ruben Reyes, (unknown), Ossama Tawfik, Douglas H. McGregor, Francisco J. Díaz, Xinkun Wang, Peter J. Van Veldhuizen	19
7	CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases 2014 ·Dermatology Online Journal ·(unknown), Janet Woodroof, Ruben Reyes, Benjamin Powers, Garth Fraga	2
8	Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia 2013 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Casey Williams, Suman Kambhampati, Warren Fiskus, Jo Wick, Catherine Dutreix, (unknown), Omar S. Aljitawi, Ruben Reyes, (unknown), Sunil Abhyankar, Kapil N. Bhalla, Joseph P. McGuirk	56
9	Results of a Phase 1 Dose-Escalation Study of Once-Weekly MLN9708, an Investigational Proteasome Inhibitor, in Patients with Relapsed/Refractory Lymphoma 2012 ·Blood ·Sarit Assouline, Julie Chang, Bruce D. Cheson, Robert M. Rifkin, Solomon I. Hamburg, Ruben Reyes, Ai‐Min Hui, Yu Jiang, Neeraj Gupta, Alessandra Di Bacco, Yaping Shou, Peter Martin	7
10	Abstract C144: Treatment with β-catenin antagonist BC2059 exhibits single agent efficacy and exerts superior activity with tyrosine kinase inhibitor (TKI) or histone deacetylase (HDAC) inhibitor against human AML, CML, and myeloproliferative neoplasm (MPN) progenitor cells. 2011 ·Molecular Cancer Therapeutics ·Warren Fiskus, Jacqueline Smith, Uma Mudunuru, Stacey L. Hembruff, Ruben Reyes, Sunil Abhyankar, Joseph P. McGuirk, Omar S. Aljitawi, Siddhartha Ganguly, Stephen Horrigan, Sunil Sharma, Kapil N. Bhalla	3
11	Treatment with Auranofin Induces Oxidative and Lethal Endoplasmic Reticulum (ER) Stress Exerting Single Agent Activity Against Primary CLL Cells 2011 ·Blood ·Rekha Rao, Kami J. Maddocks, Amy J. Johnson, Lata Chauhan, Suman Kambhampati, Siddhartha Ganguly, Ruben Reyes, Omar S. Aljitawi, (unknown), (unknown), Eileen D. Dickman, John C. Byrd, Kapil N. Bhalla	3
12	Results of a Phase I Open-Label Study of Decitabine in Combination with Midostaurin (PKC412) for Elderly (Age ≥ 60) Newly Diagnosed or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia, 2011 ·Blood ·Casey Williams, Suman Kambhampati, Siddhartha Ganguly, Omar S. Aljitawi, Ruben Reyes, (unknown), Kapil N. Bhalla, Sunil Abhyankar, Joseph P. McGuirk	1
13	Activity of Allosteric, Switch-Pocket, ABL/FLT3 Kinase Inhibitor DCC2036 Against Cultured and Primary AML Progenitors with FLT-ITD or FLT3 Kinase Domain Mutations 2011 ·Blood ·Warren Fiskus, Catherine C. Smith, Jacqueline Smith, Scott Wise, Elisabeth A. Lasater, Lauren E. Damon, Sara Salerno, (unknown), Ruben Reyes, Siddhartha Ganguly, Mark S. Berger, (unknown), Joseph P. McGuirk, Neil P. Shah, Kapil N. Bhalla	3
14	Treatment with β-Catenin Antagonist BC2059 Exerts Single Agent Efficacy and Exerts Improved Activity with Tyrosine Kinase Inhibitor (TKI) or Pan-Histone Deacetylase (HDAC) Inhibitor Against Human CML and Myeloproliferative Neoplasm (MPN) Progenitor Cells 2011 ·Blood ·Warren Fiskus, Jacqueline Smith, Uma Mudunuru, Stacey L. Hembruff, Ruben Reyes, Sunil Abhyankar, Joseph P. McGuirk, Omar S. Aljitawi, Siddhartha Ganguly, Stephen Horrigan, Sunil Sharma, Kapil N. Bhalla	2
15	Capecitabine (X) and radiotherapy (RT) in locally advanced squamous carcinoma of the uterine cervix: Phase II results 2008 ·Journal of Clinical Oncology ·Enric Domingo, (unknown), Ruben Reyes, (unknown), Pimkhuan Kamnerdsupaphon, Chawalit Lertbutsayanukul, (unknown), (unknown), (unknown), Prasert Lertsanguansinchai	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact